Novartis AG (LTS:0K9E)
$ 104.7 0 (0%) Market Cap: 209.81 Bil Enterprise Value: 227.95 Bil PE Ratio: 12.53 PB Ratio: 5.07 GF Score: 80/100

Novartis AG Investor Update on Access & Sustainability Transcript

Nov 30, 2022 / 01:30PM GMT
Release Date Price: $83.36 (+1.73%)
Unidentified Company Representative;Vasant Narasimhan

Good morning, good afternoon, good evening, everyone. Welcome to our ninth annual ESG event. Thanks for spending the time with us over the next 90 minutes. I'm going through the safe harbor statement now. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. This may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. For a description of some of these factors, please refer to the company's Form 20-F and its most recent quarterly results on Form 6-K that, respectively, were filed with and furnished to the U.S. Securities and Exchange Commission.

Today, we will have some presentations and the panel discussion. We start with Sir Ronald Cohen followed by a Q&A. And then we have Lutz Hegemann, Steffen Lang and Klaus Moosmayer, walking us through the ESG presentation, and we will do a Q&A as well to end. We start now with a video of Vas, our CEO.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot